4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propion (Q47762340)
scientific article
Language:
Current Data About 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propion
(P31) (Q13442814)
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P50) (Q42388779)
(P1545) 12
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P304) 2946-2959
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P407) (Q1860)

(P433) 16
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P478) 41
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P577) Wednesday, July 1, 1998
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P1433) (Q900316)
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P1476) "4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propion" (language: en)
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

(P2093) Pirotte B
(P1545) 1
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Podona T
(P1545) 2
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Diouf O
(P1545) 3
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

de Tullio P
(P1545) 4
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Lebrun P
(P1545) 5
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Dupont L
(P1545) 6
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Somers F
(P1545) 7
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Delarge J
(P1545) 8
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Morain P
(P1545) 9
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Lestage P
(P1545) 10
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

Lepagnol J
(P1545) 11
(P248)
(P698) 9685234
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/9685234

other details
description scientific article

External Links
(P356) 10.1021/JM970694V
(P698) 9685234